Journalists Discuss New Alzheimer’s Drug, Women’s Alcohol Use, the Hip-Hop and Opioids Link

KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.

June 12, 2021

KHN chief Washington correspondent Julie Rovner discussed the FDA’s approval of a new drug for Alzheimer’s disease on WAMU’s “1A” on Wednesday.

Click here to hear Rovner on WAMU

KHN correspondent Aneri Pattani discussed the increase in alcohol use and misuse by young women on NPR’s “All Things Considered” on Wednesday.

Click here to hear Pattani on NPR
Read Pattani’s “Women Now Drink as Much as Men — And Are Prone to Sickness Sooner”

KHN freelancer Harris Meyer discussed the FDA’s approval of a new drug for Alzheimer’s disease on Newsy on Tuesday and WCPN’s “The Sound of Ideas” on Wednesday.

Click here to watch Meyer on Newsy
Click here to hear Meyer on WCPN
Read Meyer’s “FDA Weighs Approval of a Lucrative Alzheimer’s Drug, but Benefits Are Iffy”

KHN social media manager Chaseedaw Giles discussed opioid use and hip-hop music on NBC Lx’s “First Look” on Tuesday.

Click here to watch Giles on NBC Lx
Read Giles’ “Opioids Like ‘Lean’ Permeate Hip-Hop Culture, but Dangers Are Downplayed

Copy And Paste To Republish This Story

Journalists Discuss New Alzheimer’s Drug, Women’s Alcohol Use, the Hip-Hop and Opioids Link

June 12, 2021

Article HTML

<h1>Journalists Discuss New Alzheimer’s Drug, Women’s Alcohol Use, the Hip-Hop and Opioids Link</h1>

<p>KHN chief Washington correspondent Julie Rovner discussed the FDA’s approval of a new drug for Alzheimer’s disease on WAMU’s “1A” on Wednesday. </p>

<ul><li><a href="https://the1a.org/segments/alzheimers-fda-aducanumab/">Click here to hear Rovner on WAMU</a></li></ul>

<p>KHN correspondent Aneri Pattani discussed the increase in alcohol use and misuse by young women on NPR’s “All Things Considered” on Wednesday. </p>

<ul><li><a href="https://www.npr.org/transcripts/1003980966">Click here to hear Pattani on NPR</a></li><li>Read Pattani’s “<a href="https://kffhealthnews.org/news/article/women-now-drink-as-much-as-men-and-are-prone-to-sickness-sooner/">Women Now Drink as Much as Men — And Are Prone to Sickness Sooner</a>”</li></ul>

<p>KHN freelancer Harris Meyer discussed the FDA’s approval of a new drug for Alzheimer’s disease on Newsy on Tuesday and WCPN’s “The Sound of Ideas” on Wednesday. </p>

<ul><li><a href="https://app.frame.io/reviews/1959ebc6-ac9c-42a4-8e22-f23b5be03cd3/59db16e5-1daa-4c21-9426-aea774c24ac8">Click here to watch Meyer on Newsy</a></li><li><a href="https://www.ideastream.org/programs/sound-of-ideas/fda-approval-of-alzheimers-drug-provides-hope-and-sparks-controversy">Click here to hear Meyer on WCPN</a></li><li>Read Meyer’s “<a href="https://kffhealthnews.org/news/article/fda-weighs-approval-of-a-lucrative-alzheimers-drug-but-benefits-are-iffy/">FDA Weighs Approval of a Lucrative Alzheimer’s Drug, but Benefits Are Iffy</a>”</li></ul>

<p>KHN social media manager Chaseedaw Giles discussed opioid use and hip-hop music on NBC Lx’s “First Look” on Tuesday. </p>

<ul><li><a href="https://www.lx.com/mental-health/how-to-talk-to-kids-about-drugs-when-lean-is-all-over-hip-hop-tracks/37892/?source=sm_npd_nbc_lx_twt_mn">Click here to watch Giles on NBC Lx</a></li><li>Read Giles’ “<a href="https://kffhealthnews.org/news/article/opioids-like-lean-permeate-hip-hop-culture-but-dangers-are-downplayed/">Opioids Like ‘Lean’ Permeate Hip-Hop Culture, but Dangers Are Downplayed</a></li></ul>

We encourage organizations to republish our content, free of charge. Here’s what we ask:

You must credit us as the original publisher, with a hyperlink to our kffhealthnews.org site. If possible, please include the original author(s) and KFF Health News” in the byline. Please preserve the hyperlinks in the story.

Have questions? Let us know at KHNHelp@kff.org